- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
-
- OISHI MASAO
- Department of Ophthalmology, Niigata University, School of Medicine
-
- IMAI MASAO
- Department of Ophthalmology, Niigata University, School of Medicine
-
- TAKAHASHI TAKAO
- Department of Ophthalmology, Niigata University, School of Medicine
-
- TAKIZAWA HAJIME
- Department of Ophthalmology, Niigata University, School of Medicine
-
- MOTOYAMA MARIKO
- Department of Ophthalmology, Niigata University, School of Medicine
-
- TANAKA MIKITO
- Department of Ophthalmology, Niigata Railway Hospital
Bibliographic Information
- Other Title
-
- Pivampicillinの眼科的応用のための基礎的ならびに臨床的検討
- Pivampicillin ノ ガンカテキ オウヨウ ノ タメ ノ キソテキ ナラビニ リンショウテキ ケントウ
Search this article
Description
Laboratory and clinical experiments were performed on pivampicillin in ophthalmological field, and the results obtained were as follows.<BR>1. Pivampicillin is rapidly hydrolyzed to ampicillin (ABPC) in the body. ABPC showed a broad antimicrobial spectrum against bacteria causing ocular infection. 2. The ABPC sensitivity was examined on 40 strains of Staphylococcus aureus isolated from the patients of eye infection, and it distributed in the range of ≥0.1->100mcg/ml. The peak of the distribution was seen at 6.3 mcg/ml in 40% of the strains.<BR>3. Blood concentration of pivampicillin following an oral administration of 500mg to healthy adults, reached its peak level (8.9mcg/ml) after 1 hour, and gradually decreased to 6 hours (0.18mcg/ml). A cross over study was performed with ABPC, and the peak blood level of pivampicillin was 1.5 times higher than that with ABPC.<BR>4. Following an oral administration of 50mg/kg rabbit, the aqueous levels were observed from 1 hour to 6 hours, and the peak level was obtained after 1 hour (2.9mcg/ml). Aqueous/serum ratio was 17.9-66.0%. Ocular tissue concentrations at 1 hour after an oral administration of 50mg/kg were high in the eyelid, conjunctiva, cornea, extraocular muscles, retina, chorioid, iris and ciliary body, while low in vitreous body, sclera and crystalline lens.<BR>5. Oral administration of 125-250mg pivampicillin 4 times daily revealed good therapeutic effects in 25 cases out of 27 cases of ocular infections, such as hordeolum, lid abscess, acute dacryocystitis, corneal infiltration, corneal ulcer, tenonitis and orbital phlegmon.<BR>6. As side effects, gastrointestinal disorder and rash were experienced in each case, but no other severe ones were noticed.
Journal
-
- CHEMOTHERAPY
-
CHEMOTHERAPY 22 (4), 710-716, 1974
Japanese Society of Chemotherapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206280067328
-
- NII Article ID
- 130004191476
-
- NII Book ID
- AN00186653
-
- ISSN
- 18845894
- 00093165
-
- NDL BIB ID
- 7494123
-
- Data Source
-
- JaLC
- NDL Search
- CiNii Articles
-
- Abstract License Flag
- Disallowed